General Information of Target

Target ID LDTP03490
Target Name Caspase-1 (CASP1)
Gene Name CASP1
Gene ID 834
Synonyms
IL1BC; IL1BCE; Caspase-1; CASP-1; EC 3.4.22.36; Interleukin-1 beta convertase; IL-1BC; Interleukin-1 beta-converting enzyme; ICE; IL-1 beta-converting enzyme; p45) [Cleaved into: Caspase-1 subunit p20; Caspase-1 subunit p10]
3D Structure
Download
2D Sequence (FASTA)
Download
3D Structure (PDB)
Download
Sequence
MADKVLKEKRKLFIRSMGEGTINGLLDELLQTRVLNKEEMEKVKRENATVMDKTRALIDS
VIPKGAQACQICITYICEEDSYLAGTLGLSADQTSGNYLNMQDSQGVLSSFPAPQAVQDN
PAMPTSSGSEGNVKLCSLEEAQRIWKQKSAEIYPIMDKSSRTRLALIICNEEFDSIPRRT
GAEVDITGMTMLLQNLGYSVDVKKNLTASDMTTELEAFAHRPEHKTSDSTFLVFMSHGIR
EGICGKKHSEQVPDILQLNAIFNMLNTKNCPSLKDKPKVIIIQACRGDSPGVVWFKDSVG
VSGNLSLPTTEEFEDDAIKKAHIEKDFIAFCSSTPDNVSWRHPTMGSVFIGRLIEHMQEY
ACSCDVEEIFRKVRFSFEQPDGRAQMPTTERVTLTRCFYLFPGH
Target Type
Clinical trial
Target Bioclass
Enzyme
Family
Peptidase C14A family
Subcellular location
Cytoplasm
Function
Thiol protease involved in a variety of inflammatory processes by proteolytically cleaving other proteins, such as the precursors of the inflammatory cytokines interleukin-1 beta (IL1B) and interleukin 18 (IL18) as well as the pyroptosis inducer Gasdermin-D (GSDMD), into active mature peptides. Plays a key role in cell immunity as an inflammatory response initiator: once activated through formation of an inflammasome complex, it initiates a pro-inflammatory response through the cleavage of the two inflammatory cytokines IL1B and IL18, releasing the mature cytokines which are involved in a variety of inflammatory processes. Cleaves a tetrapeptide after an Asp residue at position P1. Also initiates pyroptosis, a programmed lytic cell death pathway, through cleavage of GSDMD. In contrast to cleavage of interleukin IL1B, recognition and cleavage of GSDMD is not strictly dependent on the consensus cleavage site but depends on an exosite interface on CASP1 that recognizes and binds the Gasdermin-D, C-terminal (GSDMD-CT) part. Cleaves and activates CASP7 in response to bacterial infection, promoting plasma membrane repair. Upon inflammasome activation, during DNA virus infection but not RNA virus challenge, controls antiviral immunity through the cleavage of CGAS, rendering it inactive. In apoptotic cells, cleaves SPHK2 which is released from cells and remains enzymatically active extracellularly.; [Isoform Delta]: Apoptosis inactive.; [Isoform Epsilon]: Apoptosis inactive.
TTD ID
T98269
Uniprot ID
P29466
DrugMap ID
TTCQIBE
Ensemble ID
ENST00000436863.7
HGNC ID
HGNC:1499
ChEMBL ID
CHEMBL4801

Target Site Mutations in Different Cell Lines

Cell line Mutation details Probe for labeling this protein in this cell
CCSW1 SNV: p.G303Ter DBIA    Probe Info 
DU145 SNV: p.A321S .
HT115 SNV: p.D59N; p.Q257H .
JHH1 SNV: p.A384G DBIA    Probe Info 
KASUMI2 SNV: p.E130Ter DBIA    Probe Info 
LNCaP clone FGC SNV: p.G88Ter .
MCC13 SNV: p.P177S DBIA    Probe Info 
NCIH1703 SNV: p.T86K .
NCIH2286 Deletion: p.A66HfsTer73
SNV: p.S289C
.
SNGM SNV: p.S81N .
SW1271 SNV: p.M17V .

Probe(s) Labeling This Target

ABPP Probe
Click To Hide/Show 5 Probe Related to This Target
Probe name Structure Binding Site(Ratio) Interaction ID Ref
DBIA
 Probe Info 
C244(2.22); C43(1.77); C285(1.55)  LDD3310  [1]
Acrolein
 Probe Info 
N.A.  LDD0222  [2]
IA-alkyne
 Probe Info 
C397(0.00); C244(0.00)  LDD0167  [3]
Lodoacetamide azide
 Probe Info 
N.A.  LDD0037  [4]
Methacrolein
 Probe Info 
N.A.  LDD0218  [2]

Competitor(s) Related to This Target

Competitor ID Name Cell line Binding Site(Ratio) Interaction ID Ref
 LDCM0108  Chloroacetamide HeLa N.A.  LDD0222  [2]
 LDCM0625  F8 Ramos C285(0.85)  LDD2187  [5]
 LDCM0572  Fragment10 Ramos C285(0.82)  LDD2189  [5]
 LDCM0573  Fragment11 Ramos C285(2.13)  LDD2190  [5]
 LDCM0574  Fragment12 Ramos C285(0.84)  LDD2191  [5]
 LDCM0575  Fragment13 Ramos C285(0.89)  LDD2192  [5]
 LDCM0576  Fragment14 Ramos C285(0.67)  LDD2193  [5]
 LDCM0579  Fragment20 Ramos C285(0.58)  LDD2194  [5]
 LDCM0580  Fragment21 Ramos C285(0.97)  LDD2195  [5]
 LDCM0582  Fragment23 Ramos C285(0.65)  LDD2196  [5]
 LDCM0578  Fragment27 Ramos C285(0.94)  LDD2197  [5]
 LDCM0586  Fragment28 Ramos C285(0.89)  LDD2198  [5]
 LDCM0588  Fragment30 Ramos C285(0.94)  LDD2199  [5]
 LDCM0589  Fragment31 Ramos C285(1.02)  LDD2200  [5]
 LDCM0590  Fragment32 Ramos C285(0.84)  LDD2201  [5]
 LDCM0468  Fragment33 Ramos C285(1.15)  LDD2202  [5]
 LDCM0596  Fragment38 Ramos C285(0.87)  LDD2203  [5]
 LDCM0566  Fragment4 Ramos C285(1.06)  LDD2184  [5]
 LDCM0610  Fragment52 Ramos C285(0.89)  LDD2204  [5]
 LDCM0614  Fragment56 Ramos C285(1.06)  LDD2205  [5]
 LDCM0569  Fragment7 Ramos C285(1.44)  LDD2186  [5]
 LDCM0571  Fragment9 Ramos C285(0.98)  LDD2188  [5]
 LDCM0022  KB02 Ramos C285(0.95)  LDD2182  [5]
 LDCM0023  KB03 Ramos C285(0.82)  LDD2183  [5]
 LDCM0024  KB05 COLO792 C244(2.22); C43(1.77); C285(1.55)  LDD3310  [1]
 LDCM0131  RA190 MM1.R C331(1.33); C285(1.15)  LDD0304  [6]

The Interaction Atlas With This Target

The Protein(s) Related To This Target

Enzyme
Click To Hide/Show 7 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
NACHT, LRR and PYD domains-containing protein 1 (NLRP1) NLRP family Q9C000
Phospholipid phosphatase 1 (PLPP1) PA-phosphatase related phosphoesterase family O14494
Presenilin-2 (PSEN2) Peptidase A22A family P49810
Bleomycin hydrolase (BLMH) Peptidase C1 family Q13867
Caspase-1 (CASP1) Peptidase C14A family P29466
Ataxin-3 (ATXN3) . P54252
Pyrin (MEFV) . O15553
Transporter and channel
Click To Hide/Show 5 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Amyloid-beta precursor protein (APP) APP family P05067
Gasdermin-D (GSDMD) Gasdermin family P57764
Fibroblast growth factor 2 (FGF2) Heparin-binding growth factors family P09038
Huntingtin (HTT) Huntingtin family P42858
Wolframin (WFS1) . O76024
Transcription factor
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Mothers against decapentaplegic homolog 3 (SMAD3) Dwarfin/SMAD family P84022
Cytokine and receptor
Click To Hide/Show 1 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Interleukin-1 alpha (IL1A) IL-1 family P01583
Other
Click To Hide/Show 8 Protein(s) Interacting with This Target
Protein name Family Uniprot ID
Glial fibrillary acidic protein (GFAP) Intermediate filament family P14136
TM2 domain-containing protein 1 (TM2D1) TM2 family Q9BX74
Protein VAC14 homolog (VAC14) VAC14 family Q08AM6
Apoptosis-associated speck-like protein containing a CARD (PYCARD) . Q9ULZ3
Caspase recruitment domain-containing protein 18 (CARD18) . P57730
NLR family CARD domain-containing protein 4 (NLRC4) . Q9NPP4
Nucleotide-binding oligomerization domain-containing protein 2 (NOD2) . Q9HC29
Putative caspase recruitment domain-containing protein 17P (CARD17P) . Q5XLA6

The Drug(s) Related To This Target

Approved
Click To Hide/Show 2 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Acetylsalicylic Acid Small molecular drug DB00945
Minocycline Small molecular drug DB01017
Phase 2
Click To Hide/Show 4 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Belnacasan Small molecular drug D0HK3N
Pralnacasan Small molecular drug D0U6WQ
Ac-201 . D0WP2R
Nivocasan . D0Z2JF
Investigative
Click To Hide/Show 12 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
M826 Small molecular drug D00YNW
Pralnacasan Small molecular drug DB04875
Yvad Small molecular drug D0B3WF
Z-vad-cho Small molecular drug D0X8XO
Z-yvad-cho Small molecular drug D0P3XJ
Z-yvad-fmk Small molecular drug D0YX4V
1-methyl-3-trifluoromethyl-1h-thieno[23-c]Pyrazole-5-carboxylic Acid (2-mercapto-ethyl)-amide . DB07733
3-{6-[(8-hydroxy-quinoline-2-carbonyl)-amino]-2-thiophen-2-yl-hexanoylamino}-4-oxo-butyri Acid . DB07916
Emricasan . DB05408
Lax-101 . DB05301
Vx-765 . DB05507
Z-val-ala-asp Fluoromethyl Ketone . DB07744
Patented
Click To Hide/Show 2 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
Ac-yvad-cmk Peptide D07AVV
Ac-yvad-fmk Peptide D04KIH
Discontinued
Click To Hide/Show 3 Drug(s) Interacting with This Target
Drug Name Drug Type External ID
L-709049 Small molecular drug D0F9FA
Sdz-224-015 . D0K1CL
Ve-16084 . D0A3HF

References

1 DrugMap: A quantitative pan-cancer analysis of cysteine ligandability. Cell. 2024 May 9;187(10):2536-2556.e30. doi: 10.1016/j.cell.2024.03.027. Epub 2024 Apr 22.
Mass spectrometry data entry: PXD047840
2 ACR-Based Probe for the Quantitative Profiling of Histidine Reactivity in the Human Proteome. J Am Chem Soc. 2023 Mar 8;145(9):5252-5260. doi: 10.1021/jacs.2c12653. Epub 2023 Feb 27.
3 SP3-FAIMS Chemoproteomics for High-Coverage Profiling of the Human Cysteinome*. Chembiochem. 2021 May 14;22(10):1841-1851. doi: 10.1002/cbic.202000870. Epub 2021 Feb 18.
Mass spectrometry data entry: PXD023056 , PXD023059 , PXD023058 , PXD023057 , PXD023060
4 Enhancing Cysteine Chemoproteomic Coverage through Systematic Assessment of Click Chemistry Product Fragmentation. Anal Chem. 2022 Mar 8;94(9):3800-3810. doi: 10.1021/acs.analchem.1c04402. Epub 2022 Feb 23.
Mass spectrometry data entry: PXD028853
5 Site-specific quantitative cysteine profiling with data-independent acquisition-based mass spectrometry. Methods Enzymol. 2023;679:295-322. doi: 10.1016/bs.mie.2022.07.037. Epub 2022 Sep 7.
Mass spectrometry data entry: PXD027578
6 Physical and Functional Analysis of the Putative Rpn13 Inhibitor RA190. Cell Chem Biol. 2020 Nov 19;27(11):1371-1382.e6. doi: 10.1016/j.chembiol.2020.08.007. Epub 2020 Aug 27.